XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.10

+0.4%

Dec 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (14222)	7/24/2000 11:13:31 PM
From: aknahow	Read Replies (1) of 17367

I agree in principal but found Cacaito's post compelling. A combination product approved by the FDA would offer certain marketing advantages. I still stand by the concept that it would take 10 years to develop a combination LLY/BAX/XOMA product. Of course nothing would stop any licensed physician from combining them assuming Neuprex is approved on its own. And who's to say that might not take longer than 10 years? <g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next